Who owns MONOPAR THERAPEUTICS INC?
- Ticker: MNPR
- CUSIP Number: 61023l207
Tip: Access positions for across all investors
Analyze quarterly positions in Monopar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Monopar Therapeutics stock
Who bought or sold MONOPAR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 1.3M | $72M | 2% | Mar 2026 |
|
| RA Capital Management | 667k | $37M | 0% | Mar 2026 |
|
| Adage Capital Partners GP | 640k | $42M | -3% | Dec 2025 |
|
| Saturn V Capital Management | 326k | $21M | 110% | Dec 2025 |
|
| Deerfield Management Company | 324k | $18M | 90% | Mar 2026 |
|
| BlackRock | 317k | $17M | 24% | Mar 2026 |
|
| Vanguard Group | 294k | $19M | 41% | Dec 2025 |
|
| ADAR1 Capital Management | 264k | $15M | 13% | Mar 2026 |
|
| Wellington Management Company | 226k | $15M | -2% | Dec 2025 |
|
| Vanguard Capital Management | 219k | $12M | 100% | Mar 2026 |
|
| Siren | 212k | $14M | 100% | Dec 2025 |
|
| Balyasny Asset Management | 136k | $7.5M | 328% | Mar 2026 |
|
| TCG Crossover Management | 132k | $7.2M | -7% | Mar 2026 |
|
| Polar Capital Holdings | 106k | $6.9M | 100% | Dec 2025 |
|
| Alyeska Investment Group | 100k | $5.5M | 150% | Mar 2026 |
|
| Geode Capital Management | 100k | $5.5M | 1% | Mar 2026 |
|
| Vivo Capital | 91k | $5.0M | 0% | Mar 2026 |
|
| State Street Corporation | 84k | $5.5M | 16% | Dec 2025 |
|
| Bank of New York Mellon | 79k | $4.3M | 21% | Mar 2026 |
|
| Vestal Point Capital | 65k | $3.6M | 100% | Mar 2026 |
|
| Walleye Trading Advisors | 63k | $3.5M | 100% | Mar 2026 |
|
| Bank of America Corporation | 60k | $3.3M | 100% | Mar 2026 |
|
| Citadel Advisors | 58k | $3.2M | 1052% | Mar 2026 |
|
| Millennium Management | 53k | $2.9M | -31% | Mar 2026 |
|
| Vanguard Portfolio Management | 46k | $2.5M | 100% | Mar 2026 |
|
| UBS Group | 39k | $2.2M | 828% | Mar 2026 |
|
| Goldman Sachs Group | 35k | $1.9M | 235% | Mar 2026 |
|
| Driehaus Capital Management | 34k | $2.2M | -48% | Dec 2025 |
|
| Neuberger Berman Group | 33k | $2.1M | 100% | Dec 2025 |
|
| Northern Trust | 31k | $2.0M | 14% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 29k | $1.6M | 754% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 28k | $1.6M | 100% | Mar 2026 |
|
| Morgan Stanley | 22k | $1.2M | -17% | Mar 2026 |
|
| Squarepoint Ops | 22k | $1.2M | 107% | Mar 2026 |
|
| Barclays | 20k | $1.3M | 34% | Dec 2025 |
|
| Charles Schwab Investment Management | 14k | $933k | 21% | Dec 2025 |
|
| Russell Investments | 14k | $781k | 4079% | Mar 2026 |
|
| Renaissance Technologies | 11k | $746k | 100% | Dec 2025 |
|
| Virtu Financial | 10k | $654k | 100% | Dec 2025 |
|
| Two Sigma Investments | 9.8k | $535k | 96% | Mar 2026 |
|
| Sei Investments | 7.6k | $415k | 9% | Mar 2026 |
|
| Winton Capital | 6.8k | $374k | 100% | Mar 2026 |
|
| Ameriprise Financial | 6.8k | $374k | 100% | Mar 2026 |
|
| Eudaimonia Asset Management | 6.2k | $341k | -45% | Mar 2026 |
|
| Creative Planning | 6.0k | $328k | 100% | Mar 2026 |
|
| TD Asset Management | 5.9k | $322k | 91% | Mar 2026 |
|
| State of Wisconsin Investment Board | 5.8k | $376k | 100% | Dec 2025 |
|
| Gerber | 5.6k | $307k | 0% | Mar 2026 |
|
| Nuveen | 5.6k | $304k | 0% | Mar 2026 |
|
| Rhumbline Advisers | 4.9k | $271k | -1% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 4.6k | $251k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 4.3k | $283k | 100% | Dec 2025 |
|
| Virtus Investment Advisers | 3.6k | $233k | 100% | Dec 2025 |
|
| Your Advocates | 3.3k | $183k | 100% | Mar 2026 |
|
| MetLife Investment Advisors | 2.5k | $166k | 0% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 2.1k | $113k | -2% | Mar 2026 |
|
| Wells Fargo & Company | 1.7k | $95k | -66% | Mar 2026 |
|
| Vanguard Global Advisers | 1.6k | $85k | 100% | Mar 2026 |
|
| New York State Common Retirement Fund | 1.2k | $66k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 979.00 | $54k | -4% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 964.00 | $53k | 0% | Mar 2026 |
|
| Persistent Asset Partners | 783.00 | $43k | 100% | Mar 2026 |
|
| Meeder Asset Management | 637.00 | $35k | -36% | Mar 2026 |
|
| Goss Wealth Management | 600.00 | $33k | 0% | Mar 2026 |
|
| Legal & General Group | 408.00 | $22k | -15% | Mar 2026 |
|
| FMR | 358.00 | $23k | 2% | Dec 2025 |
|
| Tower Research Capital | 347.00 | $23k | -37% | Dec 2025 |
|
| Summit Investment Advisors | 300.00 | $16k | 0% | Mar 2026 |
|
| California State Teachers Retirement System | 247.00 | $14k | -12% | Mar 2026 |
|
| Citigroup | 232.00 | $13k | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 100.00 | $6.5k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 49.00 | $2.2k | -35% | Mar 2026 |
|
| GAMMA Investing | 29.00 | $1.6k | 107% | Mar 2026 |
|
| Sterling Capital Management | 29.00 | $1.6k | 0% | Mar 2026 |
|
| Caitong International Asset Management | 25.00 | $1.4k | -99% | Mar 2026 |
|
| CWM | 5.00 | $0 | 0% | Dec 2025 |
|
Who sold out of Monopar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Deep Track Capital | Dec 2025 | 95k | $6.2M |
| Affinity Asset Advisors | Sep 2025 | 80k | $6.5M |
| Mountain Pacific Investment Advisers | Dec 2025 | 6.1k | $398k |
| BankChampaign, National Association | Dec 2025 | 4.5k | $295k |
| Susquehanna International | Sep 2025 | 4.3k | $354k |
| Trexquant Investment | Dec 2025 | 3.8k | $247k |
| Invesco | Dec 2025 | 3.4k | $219k |
| Quest Partners | Dec 2025 | 2.0k | $130k |
| Jpmorgan Chase & Co | Sep 2025 | 1.5k | $122k |
| Canada Pension Plan Investment Board | Dec 2025 | 1.4k | $91k |
| Amalgamated Bank | Dec 2025 | 144.00 | $9.0k |